secwatch.observer — SEC 8-K summary
======================================

Issuer:     American Oncology Network, Inc. (—)
CIK:        0001839998
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0001104659-23-030111
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 2.03, 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DTOC shareholders approve extension; 75% of shares redeemed, trust account drops to $18.8M
--------------------------------------------------------------------------------

- Shareholders approved extension of business combination deadline to June 30, 2023; option for three monthly extensions to Sept 30.
- Holders of 31,502,931 shares redeemed for ~$321.2M at ~$10.19/share, leaving ~$18.8M in trust account.
- Sponsor loaned $150,000 to fund initial extension deposit into trust; note is non-interest bearing, due at close or liquidation.
- Sponsor and CFO converted all Class B shares into 8,262,500 Class A shares; those shares not entitled to trust funds.
- Company continues pursuit of business combination with American Oncology Network, LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839998/000110465923030111/0001104659-23-030111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839998/000110465923030111/tm238907d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-030111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer